Cargando…

Anti-NMDA-R encephalitis: follow-up of 24 months

Anti-N-methyl-D-aspartate receptor (anti-NMDA-R) encephalitis is the second-most-common cause of autoimmune encephalitis, based on epidemiological studies.It has been predominantly described in young females, with prominent psychiatric symptoms, memory loss, decrease in level of consciousness, epile...

Descripción completa

Detalles Bibliográficos
Autores principales: Soares, Emilia Maria Veloso, Kauark, Roberta Borges Gomes, Rocha, Maria Sheila Guimarães, Brucki, Sonia Maria Dozzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Neurologia Cognitiva e do Comportamento 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619203/
https://www.ncbi.nlm.nih.gov/pubmed/29213855
http://dx.doi.org/10.1590/S1980-57642013DN70300012
_version_ 1783267352756879360
author Soares, Emilia Maria Veloso
Kauark, Roberta Borges Gomes
Rocha, Maria Sheila Guimarães
Brucki, Sonia Maria Dozzi
author_facet Soares, Emilia Maria Veloso
Kauark, Roberta Borges Gomes
Rocha, Maria Sheila Guimarães
Brucki, Sonia Maria Dozzi
author_sort Soares, Emilia Maria Veloso
collection PubMed
description Anti-N-methyl-D-aspartate receptor (anti-NMDA-R) encephalitis is the second-most-common cause of autoimmune encephalitis, based on epidemiological studies.It has been predominantly described in young females, with prominent psychiatric symptoms, memory loss, decrease in level of consciousness, epilepsy, and central hypoventilation. The condition is commonly associated with mature ovarian teratomas. We describe a video report with a classic presentation of anti-NMDA-R encephalitis in a young patient with no identifiable tumor. Anti-NMDA encephalitis is a recognizable and treatable illness. The prognosis of patients depends on early diagnosis, implementation of appropriate immunomodulatory therapy and, in paraneoplastic cases, complete tumor removal. Clinicians should be wary of this condition, especially when assessing patients with recent onset of psychiatric symptoms unresponsive to antipsychotic treatment.
format Online
Article
Text
id pubmed-5619203
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Associação de Neurologia Cognitiva e do Comportamento
record_format MEDLINE/PubMed
spelling pubmed-56192032017-12-06 Anti-NMDA-R encephalitis: follow-up of 24 months Soares, Emilia Maria Veloso Kauark, Roberta Borges Gomes Rocha, Maria Sheila Guimarães Brucki, Sonia Maria Dozzi Dement Neuropsychol Case Reports Anti-N-methyl-D-aspartate receptor (anti-NMDA-R) encephalitis is the second-most-common cause of autoimmune encephalitis, based on epidemiological studies.It has been predominantly described in young females, with prominent psychiatric symptoms, memory loss, decrease in level of consciousness, epilepsy, and central hypoventilation. The condition is commonly associated with mature ovarian teratomas. We describe a video report with a classic presentation of anti-NMDA-R encephalitis in a young patient with no identifiable tumor. Anti-NMDA encephalitis is a recognizable and treatable illness. The prognosis of patients depends on early diagnosis, implementation of appropriate immunomodulatory therapy and, in paraneoplastic cases, complete tumor removal. Clinicians should be wary of this condition, especially when assessing patients with recent onset of psychiatric symptoms unresponsive to antipsychotic treatment. Associação de Neurologia Cognitiva e do Comportamento 2013 /pmc/articles/PMC5619203/ /pubmed/29213855 http://dx.doi.org/10.1590/S1980-57642013DN70300012 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Soares, Emilia Maria Veloso
Kauark, Roberta Borges Gomes
Rocha, Maria Sheila Guimarães
Brucki, Sonia Maria Dozzi
Anti-NMDA-R encephalitis: follow-up of 24 months
title Anti-NMDA-R encephalitis: follow-up of 24 months
title_full Anti-NMDA-R encephalitis: follow-up of 24 months
title_fullStr Anti-NMDA-R encephalitis: follow-up of 24 months
title_full_unstemmed Anti-NMDA-R encephalitis: follow-up of 24 months
title_short Anti-NMDA-R encephalitis: follow-up of 24 months
title_sort anti-nmda-r encephalitis: follow-up of 24 months
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619203/
https://www.ncbi.nlm.nih.gov/pubmed/29213855
http://dx.doi.org/10.1590/S1980-57642013DN70300012
work_keys_str_mv AT soaresemiliamariaveloso antinmdarencephalitisfollowupof24months
AT kauarkrobertaborgesgomes antinmdarencephalitisfollowupof24months
AT rochamariasheilaguimaraes antinmdarencephalitisfollowupof24months
AT bruckisoniamariadozzi antinmdarencephalitisfollowupof24months